发明名称 PIPERIDINE COMPOUND OR SALT THEREOF
摘要 A novel compound which has an excellent aurora A-selective inhibitory action and is useful as an orally administrable anticancer agent is provided. Also, a novel agent for potentiation of anti-tumor effect of microtubule agonists, which include a taxane anticancer agent, and a combination therapy are provided. A piperidine compound represented by a general formula (I) or a salt thereof: wherein, R 1 represents a carboxyl group, -C(=O)NR 5 R 6 , or an oxadiazolyl group optionally having a C 1 -C 6 alkyl group or a trifluoromethyl group as a substituent; R 2 represents a halogen atom or a C 1 -C 6 alkoxy group; R 3 represents a phenyl group optionally having 1 to 3 same or different group(s) selected from a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, and a trifluoromethyl group as a substituent; R 4 represents a hydrogen atom or a C 1 -C 6 alkyl group; and R 5 and R 6 are the same or different and each represent a hydrogen atom, a C 1 -C 6 alkyl group, or a C 3 -C 6 cycloalkyl group, or R 5 and R 6 optionally form a 3 to 6-membered nitrogen-containing saturated heterocyclic group together with a nitrogen atom to which R 5 and R 6 are bound, are provided.
申请公布号 HK1199730(A1) 申请公布日期 2017.02.03
申请号 HK20150100157 申请日期 2015.01.07
申请人 TAIHO PHARMACEUTICAL CO. LTD. 发明人 SUGIMOTO, Tetsuya;TAKAHASHI, Hidekazu;MITSUYA, Morihiro;MASUKO, Norio;SOOTOME, Hiroshi
分类号 C07D;A61K;A61P 主分类号 C07D
代理机构 代理人
主权项
地址